Literature DB >> 24880041

Anatomy of a value proposition for laboratory medicine.

Christopher P Price1, Andrew St John2.   

Abstract

Value is now becoming a key driver in the ongoing development of healthcare delivery; key facets include the identification of what is valuable and how that value can be identified, leveraged, and delivered. The concept of a value proposition is widely used in business but can be used in healthcare as a statement of the benefits, costs and value that an organization can deliver to its customers. The foundation of this statement in laboratory medicine is evidence of clinical and cost effectiveness, not only for the patient, but also for other stakeholders involved in the delivery of healthcare, e.g., the carer, service provider, commissioner, purchaser, and the supplier of the test or device, as well as society as a whole. However the value of any laboratory medicine investigation is only achieved if the output (the test result(s)), is acted upon by the initiator of the investigation. Laboratory medicine is one part of a complex intervention, and so the value proposition should encompass the breadth of that intervention - from addressing the unmet need through the generation of clinical, operational and economic outcomes. A value proposition in laboratory medicine is central to successful innovation and quality improvement in healthcare.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnostics; Evidence-based practice; Health innovation; Laboratory medicine; Technology adoption; Value proposition

Mesh:

Year:  2014        PMID: 24880041     DOI: 10.1016/j.cca.2014.05.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  The Pursuit of Value in Laboratory Medicine - Progress and Challenges.

Authors:  Andrew St John
Journal:  Clin Biochem Rev       Date:  2020-02

2.  Dissemination and Implementation of Evidence-Based Dementia Care Using Embedded Pragmatic Trials.

Authors:  Laura N Gitlin; Rosa R Baier; Eric Jutkowitz; Zachary G Baker; Allison M Gustavson; Justine S Sefcik; Nancy A Hodgson; Sokha Koeuth; Joseph E Gaugler
Journal:  J Am Geriatr Soc       Date:  2020-07       Impact factor: 5.562

3.  Evaluating diagnostic strategies for early detection of cancer: the CanTest framework.

Authors:  Fiona M Walter; Matthew J Thompson; Ian Wellwood; Gary A Abel; William Hamilton; Margaret Johnson; Georgios Lyratzopoulos; Michael P Messenger; Richard D Neal; Greg Rubin; Hardeep Singh; Anne Spencer; Stephen Sutton; Peter Vedsted; Jon D Emery
Journal:  BMC Cancer       Date:  2019-06-14       Impact factor: 4.430

4.  Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development.

Authors:  Sebastian S Fuller; Eleanor Clarke; Emma M Harding-Esch
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

5.  Improving American Healthcare Through "Clinical Lab 2.0": A Project Santa Fe Report.

Authors:  James M Crawford; Khosrow Shotorbani; Gaurav Sharma; Michael Crossey; Tarush Kothari; Thomas S Lorey; Jeffrey W Prichard; Myra Wilkerson; Nancy Fisher
Journal:  Acad Pathol       Date:  2017-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.